These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 8875794)

  • 21. Heterogenous graft rejection pathways in class I major histocompatibility complex-disparate combinations and their differential susceptibility to immunomodulation induced by intravenous presensitization with relevant alloantigens.
    Kitagawa S; Iwata H; Sato S; Shimizu J; Hamaoka T; Fujiwara H
    J Exp Med; 1991 Sep; 174(3):571-81. PubMed ID: 1678775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Examination of serum class I antigen in allograft recipient rats--origin and control of serum class I antigen.
    Sumimoto R; Fukuda Y; Shinomiya T; Asahara T; Dohi K
    Hiroshima J Med Sci; 1998 Jun; 47(2):39-45. PubMed ID: 9674339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection.
    Mieno M; Suto R; Obata Y; Udono H; Takahashi T; Shiku H; Nakayama E
    J Exp Med; 1991 Jul; 174(1):193-201. PubMed ID: 1905338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
    Arima T; Lehmann M; Flye MW
    Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency of alloantigen-specific T cytotoxic cells in high- and low-responder recipients of class I MHC-disparate heart allografts.
    Stepkowski SM; Ito T
    Transplantation; 1990 Jul; 50(1):112-9. PubMed ID: 2368131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
    Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of kidney allograft rejection across full MHC barriers by recipient-specific antibodies to class II MHC antigens.
    Priestley CA; Spencer SC; Sawyer GJ; Fabre JW
    Transplantation; 1992 May; 53(5):1024-32. PubMed ID: 1585464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intragraft gene and protein expression in rat liver allografts treated with costimulatory blockade alone or in combination with CyA.
    Bartlett AS; McCall JL; Ameratunga R; Howden B; Ramadas R; Yeong ML; Benjamin CD; Hess D; Munn SR
    J Surg Res; 2003 Nov; 115(1):1-8. PubMed ID: 14572766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
    Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
    Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "Infectious tolerance" develops after the spontaneous acceptance of Lewis-to-Dark Agouti rat liver transplants.
    Kataoka M; Margenthaler JA; Ku G; Eilers M; Flye MW
    Surgery; 2003 Aug; 134(2):227-34. PubMed ID: 12947322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4+ T-cell-dependent immune damage of liver parenchymal cells is mediated by alloantibody.
    Horne PH; Lunsford KE; Eiring AM; Wang Y; Gao D; Bumgardner GL
    Transplantation; 2005 Aug; 80(4):514-21. PubMed ID: 16123727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of CD4+ and CD8+ T cells in early and late acute rejection of small bowel allograft.
    Guo WH; Tian L; Chan KL; Dallman M; Tam PK
    J Pediatr Surg; 2001 Feb; 36(2):352-6. PubMed ID: 11172433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes.
    Bishop DK; Chan S; Li W; Ensley RD; Xu S; Eichwald EJ
    Transplantation; 1993 Oct; 56(4):892-7. PubMed ID: 8212213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Administration of anti-CD4 monoclonal antibody with intrathymic injection of alloantigen results in rat cardiac allograft tolerance.
    Arima T; Goss JA; Walp LA; Flye MW
    Surgery; 1995 Aug; 118(2):265-72; discussion 272-3. PubMed ID: 7638743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppressor cell activity of cells infiltrating rat renal allografts prolonged by perioperative administration of extracted histocompatibility antigen and cyclosporine.
    Yoshimura N; Kahan BD
    Transplantation; 1985 Dec; 40(6):708-13. PubMed ID: 2933856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Combination of CD4+ CD25+ regulatory T cell and costimulatory pathway blockade inhibits acute rejection after liver transplantation: experiment with rats].
    Shi LB; Zhang HW; Peng CH
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):942-6. PubMed ID: 17650415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
    Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
    Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
    Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
    Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of granzyme A as a marker of heart transplant rejection in cyclosporine or anti-CD4 monoclonal antibody-treated rats.
    Chen RH; Ivens KW; Alpert S; Billingham ME; Fathman CG; Flavin TF; Shizuru JA; Starnes VA; Weissman IL; Griffiths GM
    Transplantation; 1993 Jan; 55(1):146-53. PubMed ID: 8420039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerance in a rat cardiac allograft model after short-term treatment with LF 08-0299. Absence of clonal deletion and evidence of CD4+ suppressor cells.
    Andoins C; de Fornel D; Annat J; Dutartre P
    Transplantation; 1996 Dec; 62(11):1543-9. PubMed ID: 8970605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.